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Improving cell mixture deconvolution by
identifying optimal DNA methylation libraries
(IDOL)
Devin C. Koestler1* , Meaghan J. Jones2 , Joseph Usset1 , Brock C. Christensen3,4,5 , Rondi A. Butler6 ,
Michael S. Kobor2 , John K. Wiencke7 and Karl T. Kelsey6,8

Abstract
Background: Confounding due to cellular heterogeneity represents one of the foremost challenges currently facing
Epigenome-Wide Association Studies (EWAS). Statistical methods leveraging the tissue-specificity of DNA methylation
for deconvoluting the cellular mixture of heterogenous biospecimens offer a promising solution, however the
performance of such methods depends entirely on the library of methylation markers being used for deconvolution.
Here, we introduce a novel algorithm for Identifying Optimal Libraries (IDOL) that dynamically scans a candidate set
of cell-specific methylation markers to find libraries that optimize the accuracy of cell fraction estimates obtained from
cell mixture deconvolution.
Results: Application of IDOL to training set consisting of samples with both whole-blood DNA methylation data
(Illumina HumanMethylation450 BeadArray (HM450)) and flow cytometry measurements of cell composition revealed
an optimized library comprised of 300 CpG sites. When compared existing libraries, the library identified by IDOL
demonstrated significantly better overall discrimination of the entire immune cell landscape (p = 0.038), and resulted
in improved discrimination of 14 out of the 15 pairs of leukocyte subtypes. Estimates of cell composition across the
samples in the training set using the IDOL library were highly correlated with their respective flow cytometry
measurements, with all cell-specific R2 > 0.99 and root mean square errors (RMSEs) ranging from [0.97 % to 1.33 %]
across leukocyte subtypes. Independent validation of the optimized IDOL library using two additional HM450 data
sets showed similarly strong prediction performance, with all cell-specific R2 > 0.90 and RMSE < 4.00 %. In simulation
studies, adjustments for cell composition using the IDOL library resulted in uniformly lower false positive rates
compared to competing libraries, while also demonstrating an improved capacity to explain epigenome-wide
variation in DNA methylation within two large publicly available HM450 data sets.
Conclusions: Despite consisting of half as many CpGs compared to existing libraries for whole blood mixture
deconvolution, the optimized IDOL library identified herein resulted in outstanding prediction performance across all
considered data sets and demonstrated potential to improve the operating characteristics of EWAS involving
adjustments for cell distribution. In addition to providing the EWAS community with an optimized library for whole
blood mixture deconvolution, our work establishes a systematic and generalizable framework for the assembly of
libraries that improve the accuracy of cell mixture deconvolution.
Keywords: EWAS, DNA methylation, Cell mixture estimation, Cell heterogeneity
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Background
The past decade has witnessed an exponential increase
in epidemiologic studies of DNA methylation, driven in
large part by increasing appreciation for its critical role
in the development and progression of human diseases
together with the declining cost of high-throughput technologies for interrogating the epigenome. Following the
namesake adopted for genome-wide, genetic association
studies of disease phenotypes (GWAS), studies investigating the role of DNA methylation in human diseases and
exposures have been aptly dubbed epigenome-wide association studies (EWAS) [1]. While GWAS and EWAS data
share many of the same analytical challenges, the tissue
specificity of DNA methylation presents an added layer of
complexity in the analysis, and particularly in the interpretation of EWAS. Owing to the tissue specificity of DNA
methylation, it is now well established that comparisons
of methylation signatures assessed over heterogenous cell
populations are susceptible to confounding and misinterpreted associations [2–5], issues that are believed by many
to be among the foremost challenges currently facing
EWAS [6–9].
Recent attempts aimed at minimizing the potential for
confounding in the analysis of DNA methylation data
have prompted some researchers to restrict methylation assessment to purified cell populations [10, 11], for
example, CD4+ or CD14+ cells isolated from peripheral
blood. Although such studies may be less prone to confounding by leukocyte-lineage heterogeneity compared
to those involving whole blood (WB) DNA methylation assessments, purification of cell populations carrying
these markers will not completely eliminate heterogeneity attributable to lineage differences [3]. Other attempts
to address the potential for confounding in blood-based
DNA methylation data have involved adjusting statistical models with additional terms reflecting the cell
composition of study samples using, for example, measurements from complete blood cell counts (CBC) or
fluorescence-activated cell sorting (FACS) [5, 12]. However, these measurements are not often collected as part
of EWAS (Additional file 1: Table S1), the reasons for
which commonly include: insufficient quantities of substrate for both DNA methylation assessment and measurements of cell composition, budgetary constraints, and
the inability of technologies - such as FACS - to accurately measure biospecimens stored over extended time
periods. In addition, because EWAS typically represent
subsidiary studies, whose associated parent study predate
current understanding of the impact of cellular heterogeneity on DNA methylation analyses, direct measurements of cell composition were unlikely to have been
performed when biospecimens were initially collected.
These considerations, together with the emerging consensus concerning the need to account for cell composition
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in the statistical analysis of DNA methylation data
[6–9] have served to motivate the development of novel
statistical/bioinformatic methodologies for addressing the
potential confounding effects driven by cell heterogeneity [13–15]. The first of such methodologies [13] and the
most widely applied within the EWAS literature leverages the cell-specificity of DNA methylation as the basis
for estimating the cellular landscape of samples consisting
of heterogeneous cell populations. This approach, commonly referred to as cell mixture deconvolution (CMD),
is grounded on the assumption that the methylation signature for a given target sample (methylation profiled
across a diverse population of underlying cell types) can
be viewed as a weighted mixture of the unique methylation signature of each of its constituent cell types, with
weights reflecting the proportion of each cell type within
the target biospecimen. Under certain constraints, fairly
routine statistical procedures can be employed to estimate such weights, thereby providing investigators with
a “prediction” of the cellular distribution for each target
sample to which it is applied. Much in the same way one
would adjust for cell composition if cell fractions were
measured directly, estimates of cell composition obtained
using CMD can be added as additional covariate terms
to control for the potential confounding effects associated
with cell heterogeneity [16–21].
The first and most critical step of CMD and the
impetus for this research, involves assembling a library
of cell-specific methylation biomarkers that collectively
reflect the unique methylomic fingerprint of each cell
type. In the case of leukocyte subtypes, we refer to
such cell-specific methylation biomarkers as leukocytedifferentially methylated regions (L-DMRs) to convey
their differential methylation status across leukocyte subtypes. Motivated by the critical role played by L-DMR
libraries and their relationship to the accuracy of cell composition estimates [8, 22], here we develop and evaluate
a novel, iterative algorithm for Identifying Optimal LDMR Libraries (IDOL) that improves the accuracy and
efficiency of cell composition estimates obtained by CMD.
In what follows, we aim to address three key questions: (i) does the optimal library identified from IDOL
result in improved estimates of cellular composition compared to existing libraries, (ii) if so, are there discernible
differences between libraries that might offer an explanation for their prediction performance, and lastly (iii), what
impact does the difference in prediction performance
between libraries have on EWAS when estimates of cell
mixture are desired. To address these important questions
we begin by applying IDOL to a training set consisting of samples with both whole-blood DNA methylation
data (assayed using the Illumina HumanMethylation450
BeadArray (HM450)) and flow cytometry measurements
of cell composition in order to calibrate the selection of
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an optimal L-DMR library. To illustrate the utility of the
identified IDOL library as resource for future EWAS, we
benchmark its performance against existing libraries in
two independent HM450 data sets and conduct a thorough comparison of libraries to gain insight into their
observed prediction accuracy. Finally, the impact of different libraries on the false positive rate and statistical power
of EWAS is evaluated using both simulation studies and
a data application involving two large publicly available
HM450 data sets.

Results
The essential nature of library assembly and its impact
on the accuracy of cell composition estimates is highlighted in Fig. 1. Figure 1a,b depict heat maps generated
from hierarchical clustering the K = 6 major leukocyte
components of WB (i.e., CD4T cells, CD8T cells, natural killer (NK) cells, B cells, monocytes, and granulocytes)
based on their methylation signature across two different L-DMR libraries [13, 23]. The first of these libraries
to appear in the literature (TopANOVA [13]) was assembled using the 600 CpGs with the largest F-statistics
computed from a series of ANOVA models comparing
CpG-specific patterns of methylation across leukocytes
(Fig. 1a). The second library is the default library used
by the EstimateCellCounts function in the minfi Biocondutor package [23]. While also comprised of 600 CpGs,
the EstimateCellCounts library is instead assembled using
the top 100 CpGs that uniquely distinguish each cell type
from the remaining K − 1 cell types (100 × K = 600
Total CpGs). While both libraries adequately discriminate
lymphoid-derived cells (CD4T, CD8T, NK, and B cells)
from myeloid-derived cells (monocytes and granulocytes),
the EstimateCellCounts library exhibits far better discrimination of lineage-specific cell types, particularly, NK,
CD4T, and CD8T lymphocytes (Fig. 1c). The net result
of its improved discrimination of lineage-specific subtypes is uniformly better prediction performance across
the entire immune cell landscape, the largest of such gains
being associated with NK, CD4T, and CD8T lymphocytes
(Fig. 1d,e, Additional file 2: Figure S1).
The principle reason for the difference in discrimination power and prediction accuracy between libraries
is due entirely to the criteria used for their assembly.
While assembling libraries using ANOVA F-statistics
might seem reasonable, it is inherently susceptible to the
over-selection of CpGs that are capable of discriminating certain subsets of leukocytes (i.e., lymphocytes versus myeloid cell types), but provide poor discrimination
of other subsets (i.e., lineage-specific subtypes). On the
other hand, the EstimateCellCounts library is constructed
by imposing an equal representation of CpGs for each
cell type (top 100 cell-specific L-DMRs). This strategy
leads to better discrimination of lineage-specific cell types
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and, as a result, improved estimation accuracy of those
cell types (Fig. 1d,e). Despite representing an obvious
improvement over TopANOVA, the prediction accuracy
associated with EstimateCellCounts demonstrates ample
room for improvement and suggests that further refinements in the assembly of L-DMR libraries may provide the
solution.
Motivated by the critical role played by L-DMR libraries
on the accuracy of cell composition estimates, we focus
here on the development and evaluation of a novel iterative algorithm (IDOL) for identifying L-DMR libraries
that improve the performance of CMD. A schematic diagram illustrating the various steps of IDOL is given in
Fig. 2a. IDOL first involves the construction of a candidate set of L-DMRs consisting of CpG sites exhibiting
differential DNA methylation across leukocyte subtypes.
From this candidate set, subsets of L-DMRs are randomly
selected at each iteration, with each randomly selected
L-DMR being evaluated for its contribution to cell composition prediction accuracy. The contribution of each LDMR is then used to modify its probability of selection in
subsequent rounds of IDOL, where selection probabilities
are updated in a manner proportional to its contribution
to prediction accuracy. This is similar in principle to the
weight updating rule in supervised competitive learning
networks and the update rules employed in Learning Vector Quantization [24]. Specifically, L-DMRs found to contribute favorably to prediction performance are updated
to have greater chance of being selected in subsequent
iterations, whereas L-DMRs that hinder or have no effect
on prediction performance are updated to have a reduced
chance of being selected (Fig. 2b,c). This dynamic process is repeated thousands of times, with L-DMR selection
probabilities evolving at each iteration depending on how
they impact the accuracy of CMD estimates (Fig. 2d).
By updating selection probabilities in this way, randomly
selected L-DMR subsets at each sequential IDOL iteration become enriched with L-DMRs that were previously
marked as beneficial to prediction accuracy. As a result,
the temporal evolution of IDOL witnesses the preferential
selection of L-DMR subsets that, as a whole, contribute
to improved accuracy of CMD estimates (Fig. 2e,f). Upon
termination, one is left with the subset consisting of the LDMRs with the largest selection probabilities, henceforth
referred to as the optimal IDOL library.
Training the selection of L-DMR libraries for cell mixture
deconvolution

To calibrate the selection of optimal L-DMR libraries,
we first applied IDOL to a training data set consisting
n = 6 non-diseased adults with WB DNA methylation and immune profiling data (Section ‘Adult whole
blood (WB) samples’). Flow cytometry estimated cell
fractions of CD4T, CD8T, natural killer (NK), B cells,
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Fig. 1 Impact of L-DMR library on the accuracy of cell composition estimation. a, b Hierarchical clustering heat maps of the mean methylation
signatures of isolated leukocyte subtypes [3] using (a) the top 600 ANOVA-ranked L-DMRs (TopANOVA library) and (b) the 600 L-DMRs that uniquely
distinguish each cell type from all other cell types (EstimateCellCounts default library). Column dendrograms are colored to reflect the cell-lineage of
leukocyte subtypes: lymphocytes (pink) and myeloid-derived cells (blue). c Image plot showing the difference in the dispersion separability criterion
(DSC) between the EstimateCellCounts and TopANOVA libraries. For a given pair of leukocyte subtypes, larger values of DSC difference (shades of
blue) indicate better discrimination associated with the EstimateCellCounts library, whereas smaller values of DSC difference (shades of red) indicate
better discrimination associated with the TopANOVA library. d Scatterplots of the CMD predicted and FACS cell fractions for the n = 6 AdultMixed
samples. Dashed lines indicate the line of unity, dotted lines represent the fitted regression lines based on cell predictions obtained using the
TopANOVA library, and solid lines represent the fitted regression lines based on cell predictions obtained using the EstimateCellCounts library.
e Cell-specific prediction performance for the AdultMixed samples based on the TopANOVA and EstimateCellCounts libraries

monocytes, and granulocytes across the training samples are depicted in Fig. 3a. On average, granulocytes
represented the most abundant cell type across the
training samples (mean = 57.4 %, sd = 11.5 %), followed by CD4T (mean = 17.9 %, sd = 5.7 %), CD8T
(mean = 9.7 %, sd = 4.5 %), monocytes (mean = 6.7 %,
sd = 1.2 %), B cells (mean = 4.9 %, sd = 1.9 %), and NK
cells (mean = 3.5 %, sd = 1.4 %), in descending order of
abundance.
Since the objective of IDOL is to identify the best subset (or subsets) of L-DMRs from a larger candidate set of
putative L-DMRs, we first focused on constructing this
candidate set by identifying CpG sites with differential

methylation across leukocytes. Using the DNA methylation profiles for isolated leukocyte subtypes reported in
[3], we first fit a series of two-sample t-tests to compare
CpG-specific DNA methylation patterns across the K =
6 immune cell subtypes. Specifically, the CpG-specific
methylation signature of each of cell type was compared
to the K − 1 remaining cell types and the top 150 CpGs
with largest and smallest t-statistics were combined into a
single candidate list consisting of 1,800 putative L-DMRs
(Additional file 3: Table S2). Following construction of the
candidate set, we next applied IDOL to identify optimal
libraries across a range of possible library sizes, from 100
to 800 CpG loci in increments of one-hundred. Across
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Fig. 2 Conceptual illustration of the IDOL algorithm. a Schematic diagram showing each step of IDOL. b, c Illustration of the scheme for updating
the selection probabilities of L-DMRs. d Conceptual depiction of the L-DMR selection probabilities as a function of the sequential progression of
IDOL. At iteration 0, L-DMRs have an equal probability of being selected for inclusion in the randomly assembled L-DMR subset. At each sequential
iteration of IDOL (i.e., moving from left to right), the selection probabilities for L-DMRs are updated in a manner proportion to their contribution to
prediction performance; selection probabilities for L-DMRs that contribute favorably to prediction performance are increased (increasing shades of
green), whereas the selection probabilities for those that hinder prediction performance are decreased (increasing shades of red). Upon algorithm
termination, the J L-DMRs with the largest selection probabilities are taken to represent the optimal L-DMR library. e, f Plots showing mean RMSE
(M̄) and coefficient of determination (R̄2 ) respectively, as a function of sequential progression of the the IDOL algorithm

the spectrum of library sizes considered, the average R2
and root mean square error (RMSE) between flow cytometry measurements and predicted cell type proportions
obtained from the identified optimal libraries was very
stable, ranging from 0.98 to 1.00 for R2 and from 2.41 % to
3.30 % for RMSE (Additional file 4: Figure S2). As noted
in Additional file 4: Figure S2, a subtle drop-off in prediction performance was observed libraries whose size
exceeded 500 CpGs. Given the general preference for prediction models that use fewer features and because the
library consisting of 300 CpGs (Additional file 5: Table S3)
performed favorably both with respect to its average R2
and RMSE, this library was selected as the representative
IDOL library for all subsequent comparisons and analyses.

Hierarchical clustering of leukocytes based on their
mean methylation signature across the 300 CpGs in the
optimal IDOL library is given in Fig. 3b and clearly shows
better discrimination of lymphocyte subtypes compared
to the TopANOVA library (Fig. 1a). Using the IDOL
library for deconvoluting the cellular mixture of the training set samples revealed a high degree of concordance
between flow cytometry and predicted cell type proportions, with nearly perfect R2 values across all cell types and
RMSEs ranging from as low as 0.97 % for monocytes to
1.37 % for CD4T cells (Fig. 3c). Across the six leukocytes,
the average R2 and RMSE between the predicted and flow
cytometry cell type proportions were estimated at 0.99
and 1.15 %, respectively. When compared to the results
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Fig. 3 Results obtained from applying IDOL to the training set. a Stacked bar plots showing the FACS measured fractions of granulocytes (Gran),
monocytes (Mono), natural-killer cell (NK), B cells (Bcell), CD8T lymphocytes (CD8T), and CD4T lymphocytes (CD4T) across the 6 training samples.
b Hierarchical clustering heat map of the mean methylation signature of leukocyte cell-types (columns) based on the 300 optimized L-DMRs (rows)
identified by IDOL. The column dendrogram is colored to reflect the cell lineage of the leukocyte subtypes, where lymphocyte-derived subtypes are
colored pink and myeloid-derived cell types are colored blue. c Scatterplots of FACS measured cell fractions (x-axes) and predicted cell proportions
obtained using the optimized IDOL library (y-axes). Dotted lines indicate the line of unity and colored lines represent the regression line fit to the
FACS measured cell fractions and predicted cell fractions. d Overlap between IDOL and EstimateCellCounts libraries. e Image plot showing the
difference in the dispersion separability criterion (DSC) between the IDOL and EstimateCellCounts libraries for discriminating specific pairs of
leukocyte subtypes. For a given pair of leukocytes, larger values of DSC difference (shades of blue) indicate better discrimination associated with the
IDOL library, whereas smaller values of DSC difference (shades of red) indicate better discrimination associated with the EstimateCellCounts library.
f Histogram showing the results of a permutation-based testing procedure for examining the difference in the overall DSC between the IDOL and
EstimateCellCounts libraries

obtained from the application of both the EstimateCellCounts and TopANOVA libraries to training set (Fig. 1d,e,
Additional file 2: Figure S1), the IDOL library resulted better prediction performance for all cell types except B cells,
whose predictions from EstimateCellCounts exhibited
slightly lower RMSE (0.98 % versus 1.04 %). Upon further comparison, the greatest improvements in prediction
performance associated with the IDOL library occurred
for monocytes and among lymphocyte subtypes. Specifically, the IDOL library resulted in monocyte predictions
that explained approximately 70 % more variation in the
flow cytometry measurements of monocytes compared
to EstimateCellCounts (Figs. 1e and 3c). Similarly, predictions of CD4T, CD8T, and NK cell type fractions

obtained from the IDOL library explained an average of
17 % more variation in the flow cytometry derived fractions of these cell types compared to EstimateCellCounts,
and were associated with RMSEs that were on average
3.3-fold lower.
Of the 300 CpGs encompassing the IDOL library, 128
(43 %) were shared with 600 L-DMRs used by EstimateCellCounts (Fig. 3d, Additional file 5: Table S3). To
understand how differences between these two libraries
might explain their observed prediction performance,
we next compared libraries with respect to their ability to discriminate specific pairs of leukocytes. For each
library we computed the dispersion separability criterion (DSC), defined here as the ratio of the average
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distance between cell-specific centroids and the overall
mean to the average distance between samples of the
same cell type. As such, increasing DSC values indicate greater between-cell-type dispersion/discrimination.
Using the leukocyte-specific methylation data reported
in [3] as the basis for estimation, we found that the
IDOL library resulted in a significantly larger DSC
compared to the EstimateCellCounts library (permutation p = 0.038) (Fig. 3f). Furthermore, a comparison of the DSC values computed between each pair
of leukocytes showed that the IDOL library resulted in
larger DSC values in 14 out of the 15 comparisons, of
which 4 were associated with p-values that bordered
on statistical significance (p < 0.10) (Fig. 3e). Among
the 4 comparisons with marginally statistically significant p-values, 3 involved specific pairs of lymphocyte
subtypes.
Independent validation of the optimal L-DMR set

To validate the IDOL library identified in the training set, we next examined its performance for accurately deconvoluting the cellular composition of 12
additional samples spread across two independent test
sets: MethodA and MethodB sets. As described in
Section ‘Cell mixture reconstruction experiment’, the
MethodA and MethodB data sets were created by mixing purified leukocyte subtype DNA from CD4T, CD8T,
NK, B cells, monocytes, and granulocytes in predetermined proportions (Fig. 4a). As such, the true cellular mixture of the MethodA and MethodB samples are
known with a high degree of confidence, representing
ideal candidates in which to validate the optimal library
identified by IDOL in its application to the training
set.
As noted in Fig. 4a, whereas the MethodA samples are
characterized by a roughly equivalent fraction of each
cell type (mean CD4T = 11.8 %; CD8T = 20.8 %; NK =
15.0 %; Bcell = 16.0 %, monocyte = 19.2 %, and granulocyte = 17.2 %), the cellular composition of the MethodB
samples were reconstructed to resemble the immune cell
landscape observed in healthy human adults [25] (mean
CD4T = 13.2 %; CD8T = 6.0 %; NK = 3.0 %; Bcell =
2.7 %, monocyte = 6.2 %, and granulocyte = 69.0 %). Similar to the results obtained in the training set, cell type
predictions in the testing sets using the IDOL library were
highly correlated with true mixture fractions (Fig. 4b).
Specifically, the cell-specific R2 values computed across
both testing sets ranged from 0.94 (CD4T cells) to 1.00
(both, granulocytes and B cells), with an R2 of 0.97 averaged across the six cell types. In addition, the cell-specific
RMSEs computed across the testing sets showed that in 4
out of the 6 cell types, predictions were, on average, within
2.0 % of their true reconstructed mixture proportions. The
two exceptions being NK cells (RMSE = 2.5 %) and CD8T
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cells (RMSE = 3.4 %). A comparison of the cell-specific R2
and RMSEs computed within the MethodA and MethodB
data sets separately revealed relatively minor differences
in prediction accuracy (Additional file 6: Table S4 and
Additional file 7: Figure S3 and Additional file 8: Figure
S4). For the MethodA set, cell-specific R2 and RMSE
ranged between [0.86, 1.00] and [1.09 %, 4.11 %] with
mean values of 0.96 and 2.14 %, respectively. Similarly, in
the MethodB data set, cell-specific R2 and RMSE ranged
between [0.82, 0.98] and [1.44 %, 2.52 %] with mean values
of 0.91 and 1.68 %. Furthermore, there appeared to be no
association between the prediction performance of a given
cell type and its true underlying fraction in the MethodA
and MethodB reconstructed mixture samples (Additional
file 7: Figure S3, Additional file 8: Figure S4 and Additional
file 9: Figure S5).
The prediction performance obtained using the IDOL
library compared favorably to the performance associated
with EstimateCellCounts, the predictions of which
explained, on average, 2 % less variation in the underlying reconstructed mixture fractions compared to the
IDOL library (Additional file 6: Table S4 and Fig. 4c).
The largest difference in performance was observed
for CD4T cells, whose IDOL associated predictions
explained an estimated 12 % more variation in the
reconstructed mixture proportions of CD4T cells and
were associated with a 2-fold lower RMSE compared
to EstimateCellCounts (Additional file 6: Table S4
and Fig. 4c).
Implications of cell composition adjustment methodology
for EWAS

In the overwhelming majority of the studies using CMD,
estimates of immune cell fractions are first obtained
for each study sample, followed by their inclusion as
additional covariate terms in statistical models to control for the potential confounding effects of cellular
heterogeneity [26–28]. For this reason, metrics such as
R2 and RMSE, while providing a useful starting point
for comparing different L-DMR libraries, say little about
how the prediction error associated with a given library
relates to its impact on the power and false discovery
rate (FDR) of EWAS. With this in mind, we conducted
a series of analyses aimed at examining how adjustments for cellular mixture in the statistical modeling
of DNA methylation data impact the ability to correctly identify true negatives (FDR) and true positives
(power).
To understand the consequences of prediction error
in cell fraction estimates for EWAS, we first conducted
a simulation study comparing the FDR when different
strategies for cell composition adjustment were employed,
namely, when cell fraction estimates were obtained using
the IDOL and EstimateCellCounts libraries. For our
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Fig. 4 Results obtained from applying the optimal IDOL library to the testing sets. a Stacked bar plots showing the cell type fractions for each
testing set sample. b Scatter plots of the true reconstructed mixture fractions (x-axes) and the predicted cell fractions obtained using the optimized
IDOL library (y-axes). Circles indicate Method A samples and squares indicate Method B samples. Dotted lines indicate the line of unity and colored
lines represent the regression line fit to the true reconstructed mixture fractions and predicted cell fractions. c Box plots showing the predicted cell
(%) − observed cell (%) across leukocyte cell types, where blue boxes represent estimates obtained from the optimal IDOL library and red boxes
represent estimates obtained from the EstimateCellCounts library. (d, top panel) Estimated false discovery rate (FDR) for a two-group comparison of
DNA methylation as a function of the dissimilarity in the cellular distribution between groups (x-axes). Colored lines represent different approaches
for cell composition adjustment. (d, bottom panel) Difference in the FDR between the EstimateCellCounts and IDOL libraries where points above
the dotted line indicate that the EstimateCellCounts library resulted in more false positive results compared to the IDOL library. e Mean difference in
the FDR for varying sample sizes when cell mixture was adjusted using cell fractions estimates from the EstimateCellCounts and IDOL libraries. Bars
represent the 95 % bootstrap confidence intervals for each point estimate. Points to the right of the dotted line indicate that the EstimateCellCounts
library resulted in more false positive results compared to the IDOL librarys

simulations, we assumed simplistic study design that, typical of many EWAS, focused on the identification of
differentially methylated CpG sites between two groups,
i.e., case/control comparison. As described in Section
‘Simulation study comparing false discovery rates (FDR)
across different cell composition adjustment techniques’,
for each sample, methylation beta-values were simulated
for a total of 10,000 CpGs, assuming within-group sample
sizes that ranged from small/moderate (i.e., n = {50, 100})
to moderate/large (i.e., n = {250, 500}). Most importantly,
while the underlying cellular composition was permitted

to vary across groups, each cell type was assumed to
have an identical methylation signature between groups:
no group effect. As such, tests of CpG-specific differential methylation between groups with adjustments for
cellular composition should not be rejected and therefore
represent the basis for our estimates of FDR.
As expected, the FDR was appropriately controlled at
5 % when adjustments for cell composition were carried
out using the “true simulated” cell distribution (Fig. 4d,
black lines). On the other hand, a clear inflation in the
FDR was observed when tests for differential methylation
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were unadjusted for cellular composition, the degree of
inflation depending heavily on the between-group dissimilarity in cellular distribution (Fig. 4d, green lines). While
a subtle inflation in FDR was observed when cell type
adjustments were carried out using cell fraction estimates
obtained from the IDOL (blue lines) and EstimateCellCounts (red lines) libraries, the IDOL library tended to
result in a reduced number of false positive results across
the spectrum of simulation conditions (Fig. 4d). This
observation is more clearly illustrated in Fig. 4e which
depicts the average difference in FDR computed between
EstimateCellCounts and the IDOL libraries across the
range of assumed within group sample sizes. Compared
to EstimateCellCounts, the IDOL library resulted in, on
average, 2 %–5 % fewer false discoveries when withingroup sample sizes ranged from 50 to 500.
To further understand the implications of cell type prediction methodology for EWAS, we made use of two of
the largest publicly-available WB DNA methylation data
sets [16, 29]. Our analysis of the Liu [16] and Hannum
[29] data sets was aimed at addressing two different but
related questions: (i) which cell prediction methodology
performed better at explaining variation in DNA methylation within each data set and (ii) how does the additional
variation being explained relate to the statistical power of
each study. To address these questions we began by estimating the cellular distribution of the samples in each data
set using both the IDOL and EstimateCellCounts libraries
(Fig. 5a,b).
As noted in Fig. 5a,b, a high degree of correlation was
observed in the cell fraction estimates obtained using
the IDOL and EstimateCellCounts libraries, with cellspecific R2 ranging from [0.80, 0.99] and [0.84, 0.99] for
the Liu and Hannum data sets, respectively. In both data
sets, the predicted fraction of monocytes exhibited the
greatest variation between the the IDOL and EstimateCellCounts libraries, with the IDOL library resulting in
slightly smaller estimates of monocyte fractions compared
to EstimateCellCounts, on average: (5.4 % versus 7.8 %)
and (6.8 % versus 8.7 %) in the Liu and Hannum data sets,
respectively. Conversely, estimates of CD4T cells obtained
from the IDOL library were, on average, slightly larger
compared to those obtained from EstimateCellCounts;
(12.9 % versus 8.3 %) and (13.8 % versus 9.1 %) in the Liu
and Hannum data sets.
Array-wide comparisons of the proportion of CpGspecific variation in DNA methylation explained by cell
composition estimates revealed that the IDOL library
tended to explain more variation compared to EstimateCellCounts (Fig. 5c,d). Specifically, cell estimates obtained
from the IDOL library explained more variation in DNA
methylation for 83.3 % of the CpGs in the Liu data set and
74.8 % of the CpGs in the Hannum data set, both of which
represent significantly larger proportions than would be
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expected by random chance (permutation p < 0.001 for
both). To understand how these findings relate to statistical power of EWAS, we used the residual variance
estimates obtained from each methodology as the basis
for estimating the sample size required for detecting a
statistically significant difference in DNA methylation at
80 % power (Section ‘Data application for exploring the
implications of cell composition adjustment in EWAS’).
Figure 5e,f show the number of additional samples needed
when cell type correction was carried out using estimates from EstimateCellCounts (purple) or no cell type
correction (green), as a function of the desired difference to be detected in the mean methylation beta-values
between two groups. Using the residual variance estimates computed in the Hannum data set, there were
only modest differences in the number of additional
samples needed when cell type correction was based
on estimates from EstimateCellCounts, with virtually no
difference between the IDOL library and EstimateCellCounts beyond effect sizes of 0.03 (on the beta-value
scale). However, using the residual variance estimates
obtained in the Liu data set showed that, for effect
sizes ranging from 0.03–0.05 (on the beta-value scale),
approximately 15 and 5 additional samples respectively would be needed if the analysis was adjusted
for cell composition using estimates obtained from
EstimateCellCounts.

Discussion
In this manuscript, we have described and extensively
evaluated a novel, iterative algorithm for assembling LDMR libraries. Our objective was to present a methodology that can identify libraries that improve the prediction
performance of CMD. Building off existing approaches
[8, 13], IDOL involves the targeted curation of libraries
whose constituent L-DMRs are selected on the basis of
their collective ability to optimize the accuracy and minimize the prediction error associated with cell composition
estimates obtained through CMD. The principal difference between IDOL and the assembly of existing L-DMR
libraries is that IDOL makes use of a training data set
consisting of samples with both WB DNA methylation
signatures and immune profiling data as a means of calibrating the selection of L-DMRs. This in turn results in
libraries that enhance the accuracy of CMD estimates and,
as a consequence, improve the operating characteristics
of EWAS, i.e., decreased false positive rate and increased
statistical power.
In our application of IDOL to a training set, we assembled optimal L-DMR libraries across a range of possible
library sizes (i.e., 100, 200, . . . , 800) in order to examine
the relationship between library size and the accuracy of
cell composition estimates. Although only modest differences in prediction performance were observed between
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Fig. 5 Cell mixture deconvolution of the Liu and Hannum blood data sets using the IDOL and EstimateCellCounts libraries. a, b Scatter plots of the
predicted cell type fractions obtained using EstimateCellCounts library (x-axes) and the IDOL library (y-axes) for the Liu and the Hannum data sets,
respectively. c, d Distribution of the difference in the R2 computed from the IDOL and EstimateCellCounts libraries for the (c) Liu and (d) Hannum
data sets. e, f Estimated number of additional samples needed (y-axis, left) and approximate additional cost (y-axis, right) as a function of the desired
difference in DNA methylation to be detected (x-axis) when correction for cell mixture was carried out using the EstimateCellCounts library. Variance
estimates were obtained from the (e) Liu and (d) Hannum data sets

the optimal libraries identified at each size considered,
our results showed a trend toward diminishing prediction
performance for sizes exceeding 500 L-DMRs. Though
caution should be exercised when drawing conclusions
on the basis of a single analysis, these results seem suggest that when it comes to assembling libraries for CMD,
the quality of selected L-DMRs takes precedence over
their quantity (i.e., library size). Despite being half the
size, the prediction performance observed for the final
IDOL library was on par with, and in many cases better than, EstimateCellCounts across both the training and
independent testing sets. We hypothesized that the better performance associated with the IDOL library was a
result of its ability to find libraries that better characterize
the unique methylomic fingerprint of leukocyte subtypes.
To examine this hypothesis, we compared each library in

terms of how well it performed in discriminating each
pair of cell types by computing the DSC. The results of
this analysis showed that the IDOL library better discriminated 14 out of the 15 pairs of leukocyte subtypes, with
significantly improved discrimination strength across the
entire immune cell landscape. This observation is noteworthy in that it may suggest a framework for gauging the
prognostic potential of DMR libraries in the absence of
DNA methylation data sets with available immune profiling information, the “gold-standard” for assessing the prediction performance associated with different libraries.
More importantly, our results serve to illustrate a key factor underlying the accuracy of cell composition estimates
obtained via CMD, namely, that prediction accuracy is
strongly related to a library’s ability to provide a powerful
discrimination of the entire cellular landscape.
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While the library used by EstimateCellCounts is a
significant improvement over the TopANOVA approach
for library assembly, it imposes an equal number of cellspecific L-DMRs for all cell types. In principle, this would
be reasonable if cell types were mutually distinct from
one another, however this is not the case for white blood
cell types whose DNA methylation signatures are lineagespecific [3, 4, 13]. Because of the shared lineages of leukocyte subtypes, more or fewer L-DMRs might be needed
for certain cell types depending on strength of their signal, within cell-type variability of those markers, and the
lineage relationships between cell types. The data-driven
approach for assembling libraries characteristic of IDOL
indirectly addresses this issue by iteratively searching for
the subset of L-DMRs that optimize the accuracy of CMD,
with no a priori constraints on the number of cell-specific
L-DMRs used in assembly of libraries. As demonstrated
here, this approach resulted in a library that demonstrated highly accurate cell composition estimates in all
data sets considered in our examination. Although the
EstimateCellCounts library showed similar performance
across the testing sets, the results of our simulation study
and data applications showed that even modest improvements to the overall accuracy of cell fraction estimates
results in non-negligible differences in the false positive rate and statistical power for EWAS. In particular,
our simulation studies showed that when differences in
the underlying cellular distribution between groups are
large, tests of differential methylation adjusted for cell
composition estimates obtained using the default EstimateCellCounts library can lead to an estimated 5 % inflation in the false positive rate compared to adjustments
made using the IDOL library. On the scale of EWAS,
which typically involve testing hundreds of thousands to
millions of CpGs, this amounts to thousands to tens-ofthousands of CpGs being incorrectly classified as differentially methylated. Moreover, in both data applications
cell fraction estimates obtained using the identified IDOL
library demonstrated an improved ability to explain variation in whole-blood-derived DNA methylation signatures.
This lead to increased statistical power, and as a result,
fewer samples needed when cell composition correction
was carried out using the IDOL library. Although the Liu
and Hannum data applications revealed relatively minor
differences in the number of samples needed between
libraries, the corresponding cost-differential for a single
study can be on the order of several thousand dollars considering the current cost of the Illumina HumanMethylation450 array (http://www.illumina.com/), a figure whose
magnitude becomes substantial when taken across the
entire spectrum of past, present, and future EWAS involving adjustments for cell composition via CMD.
Notwithstanding the potential of IDOL to identify LDMR libraries that enhance the accuracy of cell type
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predictions obtained through CMD, this method is not
without certain limitations. As IDOL does not include
an evaluation of the prediction performance of all possible combinations of L-DMR libraries (i.e., JL ), there is
no guarantee that IDOL will arrive at globally optimal
solutions. Because of the inherent computational burden that would be required to ensure global optimality
in this case, we opted for a more computationally parsimonious approach wherein libraries are identified by
sequentially selecting L-DMR subsets preferentially comprised of L-DMRs that were previously marked as beneficial to prediction accuracy in previous IDOL iterations.
Our procedure resulted in a optimized library consisting of 300 L-DMRs, which compared favorably to existing
L-DMR libraries and demonstrated excellent prediction
performance in two independent testing data sets. Thus,
while global optimality cannot be guaranteed our results
are encouraging and provide assurance of the capacity of
IDOL to identifying libraries that result in highly accurate
estimates of cell composition.
It also deserves mentioning the the ability of IDOL to
find libraries that better characterize the unique methylomic fingerprint of leukocyte subtypes comes at the
expense of moderate increases in computational time
compared to existing techniques for library assembly.
Along these lines, the leave-one-out procedure employed
in Step 4 of IDOL may unnecessarily contribute to slower
convergence and thus increased computational demands.
To this end, bootstrap resampling [30] as a substitute for
our leave-one-out procedure may lead to faster convergence of IDOL and represents a potential opportunity
for future enhancements to this methodology. Finally,
while the applications presented herein targeted the
HM450 BeadArray, we note that IDOL is generalizable to
other platforms (i.e., whole-genome bisulfite sequencing,
Illumina HumanMethylationEPIC BeadArray, ect.) provided that the reference methylomes for isolated leukocyte subtypes are available on those platforms. As interest
in this area continues to grow, future studies should aim to
compare the L-DMR library identified here to those identified from technologies with expanded coverage of the
methylome.

Conclusions
Motivated by the critical importance of accounting for
cellular distribution when DNA methylation is assessed
in heterogeneous tissue types [6–9, 20], along with the
logistical and economic considerations that often render direct measurements of cell composition infeasible,
our work fills a critical gap in the EWAS literature by
reinforcing the importance of library assembly and its critical role in CMD. Further, we provide the epigenomics
research community with a L-DMR library, optimized
to improve the accuracy of cell distribution estimates in
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blood-derived biospecimens from human adults. Importantly, while motivated by the problem of deconvoluting
the cellular mixture of whole blood, this research provides a framework for the systematic construction of DMR
libraries in general, and represents a viable approach for
library assembly for EWAS moving forward.

Methods
In what follows, we begin by describing the DNA methylation array data sets used in this research as well as the
steps implemented in their preprocessing and quality control. We next provide an overview of cell mixture deconvolution and the IDOL algorithm. Finally, we describe
our application of IDOL, metrics employed for assessing and comparing cell type prediction performance, and
finish by describing a data application for exploring the
implications of cell composition adjustment in EWAS.
Cell mixture reconstruction experiment

Purified granulocytes, monocytes, CD4T, CD8T, natural
killer cells, and B cells from normal human subjects were
purchased from AllCells LLC (Emeryville, CA). As described (http://www.allcells.com/normal-peripheral-blood/)
ethical approval, including all consents and protocols,
have been approved by an independent review board.
Both positive and negative selection for relevant cell surface proteins was conducted by AllCells using antibodies
conjugated to magnetic beads and protocols from Miltenyi Biotec, Inc. (Auburn, CA). DNA was extracted from
purified blood leukocyte subtypes using the DNeasy blood
and tissue kit (QIAGEN, Valencia CA) or the AllPrep
DNA/RNA/Protein Mini Kit (QIAGEN) using previously
described protocols [31]. DsDNA was quantified using
a Qubit 3.0 fluorometer (Life Technologies). Following
quantification, DNA extracted from purified leukocyte
subtypes were mixed in predetermined proportions to
reconstruct two distinct sets, consisting of n = 6 samples
each. The first set of reconstructed samples used mixtures
of purified leukocyte subtype DNA in relatively equivalent proportions across the leukocyte subtypes, hereafter
referred to as the MethodA samples. For the second set
of six samples, the proportion of DNA for each leukocyte
subtype were selected to resemble their relative fractions
in the peripheral blood of normal human adult subjects
(MethodB samples). All DNA samples were bisulfite modified using the Zymo EZ DNA Methylation kit (Irvine,
CA) and epigenome-wide DNA methylation assessment
was performed using the Illumina HumanMethylation450
array platform.
Adult whole blood (WB) samples

An additional n = 6 whole blood (WB) samples from
disease-free adult donors with available immune cell
profiling data from flow cytometry were purchased from
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AllCells LLC. Inclusion and exclusion criteria for donors
as well as a statement describing the ethical approval of
such samples can be found on the AllCells LLC webpage
(http://www.allcells.com/normal-peripheral-blood/). We
hereafter refer to this data set as the AdultMixed set. DNA
extraction and bisulfite modification of the AdultMixed
samples followed an identical protocol to that described
above, with epigenome-wide DNA methylation profiling performed using the Illumina HumanMethylation450
array platform.
Reference DNA methylomes for isolated leukocyte
subtypes

To identify L-DMRs and as the basis of all applications of
CMD, we used a publicly available data set (GEO Accession ID: GSE35069) consisting of epigenome-wide DNA
methylation profiles for the same six leukocyte subtypes
used in our reconstruction experiments. Further details
concerning the study participants, purification of blood
cell populations, and DNA extraction have been previously described [3].
Additional DNA methylation data sets

In addition to the aforementioned data sets, we also made
use of two of the largest publicly available blood-derived
DNA methylation data sets currently available on Gene
Expression Omnibus (Accession numbers: GSE42861 and
GSE40279). Collectively, these two data sets consist of
WB DNA methylation data on >1200 adult patients
and were used here for the purpose of understanding
the implications of cell mixture adjustment when mixture fractions were estimated using differing L-DMR
libraries. The first data set (Liu) consisted of bloodderived DNA methylation data on 689 human subjects,
including n = 354 rheumatoid arthritis and n = 335
non-diseased control patients [16]. The second data set
(Hannum) included blood-derived DNA methylation data
on 656 non-diseased adults, ranging in age from 19 to 101
years old [29]. For both data sets, epigenome-wide DNA
methylation assessment was performed using the Illumina
HumanMethylation450 array platform.
Quality control and preprocessing of the DNA methylation
data sets

For each of the data sets used in this research (Table 1),
background subtraction and normalization utilizing
various internal controls present on the Methylation450
BeadChip was conducted using the publicly available,
minfi Bioconductor package (http://bioconductor.org).
Every beta-value on the HumanMethylation450 array
platform is accompanied with a detection p-value, representing the confidence that the signal intensities for
that locus exceed the background defined by the negative control probes. To ensure high-quality methylation
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Table 1 Summary of the data sets used in this research
Biospecimen

Name

Details

N

Training or
testing

GEO ID

Description

Whole Blood (WB)

AdultMixed

Unfractioned peripheral
blood leukocytes (PBL)

6

Training

GSE77797

DNAm profiling of WB
samples collected from 6
different healthy adult
donors.

MethodA

Reconstructed cell mixtures

6

Testing

GSE77797

DNAm profiled in samples
consisting of mixtures of
CD4T, CD8T, NK, B cells,
Monocytes, and Granulocytes,
mixed predetermined
proportions

MethodB

Reconstructed cell mixtures

6

Testing

GSE77797

DNAm profiled in samples
consisting of mixtures of
CD4T, CD8T, NK, B cells,
Monocytes, and Granulocytes,
mixed predetermined
proportions

Liu

Unfractioned peripheral
blood leukocytes (PBL)

689

Testing

GSE42861

DNAm profiled in WB
samples collected from
n = 354 rheumatoid
arthritis and n = 335 nondiseased control patients
[16]

Hannum

Unfractioned peripheral
blood leukocytes (PBL)

656

Testing

GSE40279

DNAm profiled in WB
samples collected from a
total of 656 adults ranging
in age from 19–101 years
old [29]

Granulocytes (Gran)

Purified CD16+ cells

6

Both

GSE35069

DNAm profiling in purified
cell types [3]

Monocytes (Mono)

Purified CD14+ cells

6

Both

GSE35069

DNAm profiling in purified
cell types [3]

B cells (Bcell)

Purified CD19+ cells

6

Both

GSE35069

DNAm profiling in purified
cell types [3]

Natural Killer (NK)

Purified CD56+ cells

6

Both

GSE35069

DNAm profiling in purified
cell types [3]

CD8T

Purified CD3+CD8+ cells

6

Both

GSE35069

DNAm profiling in purified
cell types [3]

CD4T

Purified CD3+CD4+ cells

6

Both

GSE35069

DNAm profiling in purified
cell types [3]

Isolated cell types (Reference set)

data, CpG loci having a sizable fraction (>25 %) of
detection p-values above a predetermined threshold
(detection p > 10−5 ) were excluded from our analysis
[20]. Also, we employed Subset quantile within arraynormalization (SWAN) to adjust the beta-values of type
2 design probes into a statistical distribution characteristic of type 1 probes [32]. Finally, the presence of
batch-effects, or technical sources of variability induced
by plate and/or BeadChip, was assessed using principal
components analysis (PCA) [33, 34]. Specifically, PCA
was fit to the background subtracted and normalized
methylation data and the top S principal components
(S determined using a previously described approach
[35]) were examined in terms of their association with
plate and BeadChip. If plate and/or BeadChip was
found to be significantly associated with any of the

top S principal components (p < 0.05), we applied
ComBat [36, 37], an empirical Bayes batch-adjustment
methodology that has become a standard pre-processing
technique for array-based DNA methylation data
[7, 20, 38].
Cell mixture deconvolution

To motivate the IDOL algorithm, we provide a brief
description of CMD, referring interested readers to
Houseman et al. (2012) for further details. Let Yi =
[ Yi1 , Yi2 , . . . , YiJ  ] represent the methylation beta-values
across J  CpG loci for target sample i. Further assume that
for target sample i, DNA methylation was assessed over a
heterogeneous cell population, comprised of a mixture of
K underlying cell types whose proportions within sample
i are given by: ωi =[ ωi1 , ωi2 , . . . , ωiK ].
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As first described in Houseman et al. (2012), the methylation signature of sample i is assumed to arise as a
weighted mixture of the DNA methylation signature of
each of the K underlying cell types:
E[ Yi ] = ωi μ ,

0 ≤ ωik ≤ 1 and

K


ωik ≤ 1

(1)

k=1

where μ is a J  × K matrix of mean methylation betavalues whose rows represent the same ordering of the J 
CpGs in Yi and whose columns represent the K distinct
cell types. Thus, the (jk)th element of μ represents the
population mean beta-value for CpG j among cell type
k. Following from Eq. (1), the objective of CMD involves
estimating the mixture weights ω̃i that minimize:
argminωi ||Yi − ωi μ ||2

(2)

subject to the aforementioned constraints on ωi . Because
μ is unobserved in practice, it is substituted with its
sample mean M, estimated from one of several possible
existing reference methylation data sets [3, 13].
The mainstay of CMD is that knowledge of the methylomic fingerprint of each cell type - represented by the column space of M - can be used to estimate their fractions
within a sample consisting of a heterogenous mixture of
those same cell types, Yi . As such, the ability to accurately estimate the underlying mixture composition of a
given target sample depends entirely on the J  CpGs (i.e.,
L-DMR library) being used as the basis of CMD. Ideally,
L-DMR libraries should consist of CpGs whose methylation signature is maximally distinct across the K cell types
and whose within-cell-type variation is minimal. Hence,
efforts to improve the accuracy of cell composition estimates obtained through CMD should focus on identifying
L-DMR libraries that satisfy the above criteria. To date,
several strategies have been been proposed for assembling
L-DMR libraries.
The first of such strategies involved assembling libraries
using the J   J CpGs with the largest F-statistics computed from a series of ANOVA models fit to the DNA
methylation profiles of purified isolated leukocyte cell
types [13]. While reasonable in principle, using ANOVA
F-statistics as the criteria for constructing libraries has
the major limitation that libraries can become oversaturated with CpGs that discriminate certain leukocyte
subsets (i.e., lymphoid- versus myeloid-cell-types), but
lack sufficient signal for distinguishing closely related
cell types. Recent attempts to address the limitations of
the “ANOVA-based” strategy have instead used the top
L hyper- and hypomethylated CpGs for each cell type,
selected from a rank ordering of CpGs by their t-statistic
computed from two-sample t-test comparisons of the
methylation signature of each cell type against all other

cell types [8]. This procedure is implemented in the Bioconductor package minfi:EstimateCellCounts [23], where,
by default, the top 50 hyper- and hypomethylated CpGs
for each cell type (i.e., CD4T, CD8T, NK, B cell, monocyte,
granulocyte) are used to assemble the L-DMR library. By
imposing an equal representation L-DMRs for each cell
type, this strategy is much less prone to the oversaturation
problem characteristic of the “ANOVA-based” approach;
the net effect being improved discrimination of closely
related cell types and as a result, more accurate estimates
of cell composition.
Algorithm for the optimal selection of L-DMRs

While the strategy for library assembly used by EstimateCellCounts is less susceptible to the types of issues
that can arise when rank ordering CpGs using the Fstatistic, it has several limitations that may curtail the
accuracy of cell fraction estimates. In particular, because
CpGs are selected irrespective of any evaluation of their
contribution to the accuracy of cell fraction estimates,
the EstimateCellCounts library may not necessarily coincide with the optimal set of CpGs for cell composition prediction. In addition, EstimateCellCounts uses a
library that is comprised of an equal number of cellspecific L-DMRs (i.e, top 50 hyper- and hypomethylated
cell-specific CpGs). While preventing scenarios where
libraries are oversaturated with CpGs that only discriminate certain subsets of leukocytes, the assumption of an
equal number of cell-specific CpGs may not necessarily correspond with optimal prediction accuracy. Finally,
although using top hyper- and hypomethylated CpGs
across each cell type for library assembly is an intuitive
and sensible approach, it is possible that there exists a
non-overlapping set of L-DMRs that outperform the top
hyper- and hypomethylated CpGs in terms of prediction
accuracy.
To address the limitations of existing L-DMR libraries,
we propose IDOL, an algorithm that iteratively searches
for libraries that improve the accuracy and precision of
CMD. It is important to note that IDOL requires a training data set for calibrating the selection of optimal DMR
libraries. For example, when focus is centered on identifying optimal DMR libraries for deconvoluting peripheral
blood, training data sets should consist of samples with
both WB DNA methylation signatures and direct measurements of the underlying cell distribution of those
samples; i.e., CBC, FACS, etc. In what follows, we provide a detailed description of each step of the IDOL
algorithm.
Step 0: Construction of the candidate L-DMR search
space
a. Similar to [8], a series of two-sample t -tests (or
similar methodology) are fit to the J arrayed CpGs
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and used to compare the mean methylation
beta-values between each cell type against the mean
beta-values computed across all other cell types.
b. Identify the L/2 CpGs with the largest t -statistics and
the L/2 CpGs with the smallest t -statistics for each
of the K cell types, where L is a tuning parameter
representing the number of cell-specific L-DMRs.
c. Construct a set Q, which consists of the L
cell-specific L-DMRs identified in (b). Thus, Q is
comprised of P = L × K putative L-DMRs, and
represents the candidate search space for the
subsequent steps of IDOL. It should be noted that
there are trade-offs in the selection of L. Whereas
large values of L broaden the candidate space in
which to search for optimal L-DMR libraries, this
comes at the expense of increased computational
burden. Conversely, while small L results in lower
computational costs, this comes with the risk
missing potentially predictive L-DMRs due to a
narrower candidate search space. Since the IDOL
algorithm needs to be applied only when the
reference methylomes for “new” cell types are added
to those that currently exist (i.e., CD4T, CD8T, NK,
Bcell, Monocytes, and Granulocytes), or if one
wishes to identify optimized L-DMR libraries based
on different technologies for interrogating the
methylome (i.e., Illumina Human Methylation EPIC
BeadArray, whole genome bisulfite sequencing, etc.),
we advise users to select L to be arbitrarily large to
ensure a broad enough candidate search space.
d. In addition to pre-selecting L, the user also needs to
pre-select J   P, representing the library size. It is
important to note that special care should be given
in the selection of J  , as the accuracy and precision
of cell proportion estimates are sensitive to its
specification [22]. We provide specific suggestions
its selection at the end of this section.
Step 1: Random assembly of L-DMR libraries
a. At iteration , J  CpGs are randomly selected from
Q with probability πj() , j = 1, 2, . . . , P. At iteration
0, every CpG among the P candidate L-DMRs has an
(0)
equal chance of being selected, i.e., πj = 1/P,
∀j ∈ Q.
b. Let Q() ⊂ Q represent the randomly assembled
L-DMR library, comprised of the J  randomly
selected CpGs at iteration .
Step 2: Cell composition estimation using randomly
assembled library
a. Using the randomly assembled library Q() , apply
CMD to a training set to obtain cell composition
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estimates: ω̃i , where i = 1, . . . , N1 and N1 represents
the number of training samples.
b. The resulting set of predictions are given as
˜ =[ ω̃1 , ω̃2 , . . . , ω̃N1 ], where 0 ≤ ω̃i ≤ 1 is a K × 1

vector of the predicted cell proportions for training
˜ k =[ ω̃1k , ω̃2k , . . . , ω̃N k ] as
sample i. Further define 
1
the predicted proportions for cell type k across the
N1 training samples.
Step 3: Assessing the accuracy of cell composition
estimates: Given the strengths and limitations of purely
relative and absolute measures for assessing prediction
performance [39], we propose using both the R2 and root
mean square error (RMSE) as the basis for our assessments. Let  = [ ω1 , ω2 , . . . , ωN1 ] represent the observed
cell proportions for the N1 target samples obtained via
CBC, FACS, etc. The proportion of variation in the
observed fraction of cell-type k (k ) explained by its
˜ k ) is computed as:
predicted fraction (
R2k = 1 −

k ) (k − 
k )1N
1N1 (k − 
1
,


¯
¯
1N1 (k − k ) (k − k )1N1

0 ≤ R2k ≤ 1

N1
¯k =
where 
i=1 k /N1 is an estimate of the mean
k represents the
observed fraction of cell-type k and 
˜ k . In
linear predictor obtained from regressing k on 
particular,
k = 
β k ˜k




2
where, 
β k = (˜k ˜k )−1 ˜k k . Thus, R̄2 = K1 K
k=1 Rk
represents an estimate of the mean coefficient of determination across the K cell types. Additionally, the RMSE
for cell type k = 1, 2, . . . , K is computed here using the
following expression:

RMSEk =

˜ k ) (k − 
˜ k )1N1
1N1 (k − 

N1
0 ≤ RMSEk < ∞

,


with M̄ = K1 K
k=1 RMSEk representing an estimate of
the mean RMSE across the K cell types. Given the above,
IDOL seeks to find L-DMR libraries whose cell-type
predictions minimize M̄ and maximize R̄2 . As described
in further detail below, both M̄ and R̄2 are used for determining the contribution of each CpG in Q() on overall
prediction performance.
Step 4: Leave-one out procedure: In order to assess the
individual contribution of each CpG in Q() , we implement the following leave-one-out procedure:
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a. Each of the J ∗ CpGs contained in Q() are iteratively
()
removed to obtain the following sets Q−j , which
include all CpGs in Q() , except for CpG j.
()
b. Steps 2–3 are repeated for each reduced library Q−j
and used to obtain (M̄−j , R̄2−j ); estimates of the
overall RMSE and coefficient determination when
CpG j is excluded from the L-DMR library.
Conceptually, when R̄2−j is small relative to R̄2 , this
suggests that withholding CpG j from Q() resulted
in predictions that, on average, accounted for a
smaller proportion of variation in the observed cell
fractions. Conversely, when R̄2−j > R̄2 , withholding
CpG j from Q() resulted in predictions that
accounted for a larger proportion of variation in the
observed cell proportions. A similar argument holds
for the relationship between M̄−j and M̄.
c. From (b), it is clear that in subsequent IDOL
iterations we would want to preferentially keep
CpGs whose M̄ − M̄−j < 0 and R̄2 − R̄2−j > 0. This
observation implies a framework for updating the
selection probabilities of each CpG.

receives more weight. The increment for modifying
the selection probability of CpG j is given as:
p−j = r−j cos(θ−j − π/4),

For the purpose of exposition, when δ = 1/2, CpGs
with the largest increment in selection probability
(i.e., large p−j ) are those with large r−j and θ−j close
to π/4 radians (Fig. 2b,c). Conversely, CpGs with the
largest decrease in selection probability (i.e., small
p−j ) are those with large r−j and θ−j close to 5π/4.
When p−j ≈ 0, this implies that either r−j is small or
θ−j is close to (3π/4, −π/4) radians and suggests
that withholding CpG j from Q() is neither helpful
nor detrimental to prediction performance. In these
situations, the selection probability should remain
unchanged.
c. This brings us to the following procedure for
updating selection probabilities,
(+1)
πj

(+1)

=

and RMSE are measured on different
a. Since
scales, we begin by normalizing both M̄−j and R̄2−j to
obtain U−j and V−j , j = 1, . . . J ∗ respectively:
U−j

M̄−j − M̄
,

=
sd M̄−j

V−j

R̄2−j − R̄2

=
sd R̄2−j

where −∞ < U−j < ∞ and −∞ < V−j < ∞.
b. Noting that CpG j should be preferentially updated
to have a larger probability of selection when both
U−j and −V−j are large, we generate a composite
measure by first converting (U−j , −V−j ) from the
Cartesian coordinate system to the polar coordinate
system:
r−j =

ρj

(+1)

0 ≤ πj

≤ 1 (3)

πj() expit(p−j ) + πj() /2

if j ∈ Q()

(+1)
j∈Q ρj

,

where,

Step 5: Updating selection probabilities:
R2

−∞ ≤ p−j ≤ ∞

ρj(+1) =

πj()

if j ∈ Q()
(4)

and expit is the inverse-logit function, i.e.,
expit(x) = exp(x)/(1 + exp(x)). Thus, selection
probabilities for each j ∈ Q() are modified based on
how beneficial/not beneficial each CpGs was
determined to be in the presence of the remaining
J  − 1 CpGs. As noted from Eqs. (3 and 4), the
probability of selection is unchanged for CpGs
j ∈ Q() as well as for CpGs where p−j ≈ 0.
Step 6: Continue Iteration: Using the updated proba(+1)
, j = 1, . . . , P, repeat steps 1-5. The final
bilities, πj
solution consists of the library comprised of the J  CpGs
with the largest selection probabilities (Fig. 2).

2 + (1 − δ)(−V )2
δU−j
−j

θ−j = atan2(−(1 − δ)V−j , δU−j )
where atan2 is a common variation of the arc
tangent function, r−j is the radial coordinate, θ−j is
the angular coordinate, and 0 ≤ δ ≤ 0 is a parameter
that controls the balance between relative and
absolute prediction performance. For example, when
δ = 1/2, a CpG’s influence on relative and absolute
prediction performance receives equal weight. When
δ → 1 a CpG’s influence on absolute prediction
performance receives more weight and when δ → 0,
a CpG’s influence on relative prediction performance

As previously described, because the accuracy and precision of cell proportion estimates are sensitive to the
specification of J  , special treatment should be given
towards its selection. Although computationally demanding, our strategy for determining J  involves fitting IDOL
across a range of possible values for J  , (i.e., J  =
{50, 100, 200, . . .}) followed by a comparison of prediction
performance across each of the specified values. Under
such a framework, we select the smallest value of J  upon
which the gains in prediction performance for increasing
values of J  is minimal, (i.e., within some predetermined
tolerance of the performance metrics).
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Application and assessment of IDOL
Training the L-DMR selection algorithm

To examine the robustness of IDOL, we employed
a training and testing procedure and benchmarked
theprediction performance of the library identified by
IDOL against the widely used EstimateCellCounts function in the minfi Bioconductor package. Specifically, we
first applied IDOL to the AdultMixed samples (Training
Set) to identify “optimal” L-DMR libraries for deconvoluting the cell distribution of whole blood. As previously described, the AdultMixed samples consisted of
both flow cytometric measurements and whole blood
DNA methylation data derived from the same set of
biospecimens used for flow cytometry. To examine the
sensitivity of prediction performance based on the number of L-DMRs used for deconvoluting cellular mixture,
we applied IDOL to the training samples assuming a
range of possible values for J  , specifically assuming J  =
{100, 200, 300, 400, 500, 600, 700, 800}. The final selection
of J  and the representative IDOL library used in our
subsequent validation analyses was chosen to be the
value J  that resulted best prediction performance in
the training set. Finally, in training the IDOL algorithm,
selection probabilities of putative L-DMRs were updated
assuming equal weights in terms of their contribution to relative and absolute prediction performance,
i.e., δ = 1.
Following the application of IDOL to the training set,
we next examined the overlap between the “optimal”
IDOL library and the 600 L-DMRs currently used by
EstimateCellCounts. In order to comprehend the nature
of the difference between these libraries and how such
differences might influence their propensity for accurate
cell fraction estimates, we computed the dispersion separability criterion (DSC). The DSC was initially developed
as a metric for quantifying the extent of batch effects
in ’omic data sets, and is computed as the ratio of the
average distance between batch centroids and the global
mean (Dbetween ) and the average distance between samples belonging to the same batch (Dwithin ). Larger values of DSC indicate greater dispersion between batches
than within batches; i.e., samples within batches are more
homogeneous compared to samples in different batches.
In the same way, the DSC can be used for quantifying
the dispersion between and within specific leukocyte subtypes based on a given set of L-DMRs, substituting batch
with cell-type identity of a given sample. Using reference DNA methylation data profiled across the six major
leukocyte components of whole blood [3], we computed
the overall DSC and the DSC between each pair of cell
types (i.e., CD4T vs CD8T, CD4T vs NK, etc.) using both
the “optimal” IDOL library and the EstimateCellCounts
library. Equation 5 provides the DSC formula for pairwise comparisons, where (r, s) denotes the two cell types
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(r, s)

being compared, Dbetween represents the the average distance between cell type centroids and the global mean,
(r, s)
and Dwithin represents average distance between samples
of the same cell type.
DSC (r, s) =

(r, s)

Dbetween
(r, s)

Dwithin

, (r, s) ∈ {(1, 2), . . . ,

(5)

(1, K), . . . , (K − 1, K)}
In order to assess which L-DMR library exhibited better
performance at discriminating specific pairs of cell types
(i.e., (r, s)), we computed the difference between DSCs calculated from the IDOL and EstimateCellCounts libraries
(Eq. 6).
(r, s)

(r, s)

(r, s)

= DSCIDOL − DSCEstimateCellCounts

(6)

Based on Eq. 6, (r, s) = 0 signifies no difference
between the IDOL and EstimateCellCounts libraries for
discriminating cell types r and s, whereas large positive or negative values of (r, s) signify improved discrimination associated with the IDOL library (former)
or the EstimateCellCounts library (latter). To test the
hypothesis that (r, s) = 0, we conducted a nonparametric, randomization-based test. Specifically, pvalues were computed by comparing the observed DSC
differences to the empirical null distribution, generated through repeated random permutations of the data.
Randomization-based p-values less than 0.05 were treated
as statistically significant.
Independent validation of the optimal L-DMR set

To validate IDOL, we applied CMD to two independent
test sets (MethodA and MethodB sets) using the optimal
IDOL library identified in the training set. Our choice to
use the MethodA and MethodB samples as our testing
sets was motivated by the fact that the samples in both
sets were obtained by mixing leukocyte subtype-specific
DNA in known, predetermined proportions. Thus, for
a given sample, the underlying leukocyte fractions are
known with high confidence and are likely less prone to
the measurement error associated cell sorting/counting
techniques. As such, the MethodA and MethodB sets
represent ideal data sets for validating the prognostic performance of the optimal L-DMR library identified in the
training set.
To assess the performance of our cell type predictions, we estimated the proportion of variation of the
known, reconstructed mixture fractions explained by our
cell type predictions (i.e., R2 ) as well as the average deviation between the reconstructed mixture fractions and
our predictions (i.e., RMSE). R2 and RMSE were computed for each cell type individually, across all testing
samples and within each testing set separately. The rationale for latter was to examine the robustness of the IDOL
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library when the underlying cellular landscape differed
(see Section ‘Cell mixture reconstruction experiment’
for further details on the MethodA and MethodB reconstruction experiment). As an additional comparison and
to benchmark the performance of the IDOL library
for accurately deconvoluting cellular mixture, we also
applied the minfi:EstimateCellCounts function (using its
default options). In a similar manner, cell-specific R2 and
RMSE were computed based on the cell type predictions obtained from EstimateCellCounts, both within and
across the two MethodA and MethodB sets.
Simulation study comparing false discovery rates (FDR)
across different cell composition adjustment techniques

To understand the consequences of prediction error in
cell fraction estimates for EWAS, we conducted a simulation study to compare the false discovery rate (FDR)
when different strategies for cell composition adjustment
were employed. For our simulations, we assumed simplistic study design that, typical of many EWAS, focused on
the identification of differentially methylated CpG sites
between two groups, i.e, case/control comparison. To
determine if the relationship between cell composition
adjustment method and FDR was sensitive to the study
sample size (i.e., n = n1 + n2 ), we conducted separate simulations that ranged from small/moderately sized studies
(i.e., n1 , n2 = {50, 100}) to large studies (i.e., n1 , n2 =
{250, 500}). In addition to varying the sample sizes of each
group, we also examined the relationship between FDR as
a function of the dissimilarity in the true, simulated cell
distribution between the two groups.
To motivate the design of our simulation study, we
assumed that the methylation beta-value for CpG j among
target sample i, Yij , follows a beta-distribution with expec(1−ωi μ )ωi μ

j
j
, respectation and variance given by: ωi μj and
1+φj
tively. As previously, ωi is vector of length K representing
the true underlying cell fractions for sample i, μj is a
vector whose elements represent the population mean
beta-values for CpG j across the K cell types, and φj > 0 is
the unobserved dispersion parameter for CpG j. Letting Xi
denote the group membership for sample i, many EWAS
involve fitting regression models that have the following
form:

Yij = α0j + α1j Xi +

K−1


γkj ωik +

k=1

E[

ij ] =

ij ,

(7)

0 and V[ ij ] = σj2


where the term K−1
k=1 γkj ωik is introduced to control for
cell composition differences across subjects and ij captures the remaining variation in methylation after taking
group status and cellular composition into account. In the
above regression model, interest is typically centered on

testing the hypothesis of no difference in DNA methylation levels between groups, i.e., α1j = 0. However, in
practice ωik is unknown and typically substituted with its
estimate ω̃ik , obtained for example by CMD [13]. Since ω̃ik
is an estimate and therefore subject to uncertainty, tests
of hypothesis and confidence intervals based on model 7
can become unreliable and prone to inflated Type 1 and 2
error rates.
To examine how cell type prediction errors associated
with the IDOL and EstimateCellCounts libraries impact
the FDR for testing α1j , we first estimated the uncertainty
of cell fraction predictions for each method by squaring
the RMSEs computed across the MethodA and MethodB
testing sets to obtain the mean squared prediction errors
(MSPEs):
2
=

τkl2 = MSPEkl = RMSEkl

N
1 
(ωik − ω̃ikl )2 ,
N
i=1

(8)

k = 1, 2, . . . K
where l is an index representing the library used for CMD
(i.e., l = {EstimateCellCounts, IDOL}) and N represents
the total sample size for the testing data (i.e., N = 12
for the MethodA and MethodB sets). After obtaining estimates of precision, 
τkl2 , we implemented the following
seven steps in our simulation study:
1. Randomly sample G = 10, 000 CpGs from the
Illumina HumanMethylation450 array.
2. Estimate the dispersion parameter within the
combined testing sets for each of the G randomly
g , g = 1, 2, . . . G. In addition, using
selected CpGs, φ
the reference leukocyte methylation data [3], estimate
cell-specific mean methylation beta-values for each of
the G CpGs, mkg , g = 1, 2, . . . G and k = 1, 2, . . . K .
Parameter estimation was carried out using method
of moments estimation.
3. Randomly generate the cell distribution for groups 1
and 2.
a. For group 1, simulate the cell distribution, ω(1) ,
from a Dirichlet distribution with concentration
(1) (1)
(1)
parameters, ν (1) =[ ν1 , ν2 , . . . νK ].
b. For group 2, simulate the cell distribution, ω(2) ,
from a Dirichlet distribution with concentration
parameters, ν (2) =[ ν1(2) , ν2(2) , . . . νK(2) ].
4. For both groups, simulate methylation beta-values for
each of the G CpGs from a beta-distribution.
a. For each of the n1 samples in group 1, randomly
(1)
sample beta-values Yig from a beta-distribution
with mean ω(1) mg and variance

(1−ω(1) mg )ω(1) mg
.
g
1+φ
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b. For each of the n2 samples in group 2, randomly
(2)
sample beta-values Yig from a beta-distribution
with mean ω(2) mg and variance

(1−ω(2) mg )ω(2) mg
.
g
1+φ

5. Randomly sample cell type predictions for each
(1)
(2)
sample (i.e., ω̃il and ω̃il ) based using the
cell-specific uncertainty estimates (Eq. 8) associated
with the EstimateCellCounts and Optimized L-DMR
methods.
(1)

a. For each of the n1 samples in group 1, obtain ω̃il
by randomly sampling from a multivariate normal
distribution with mean ω(1) and variance(1)
τkl2 ), k = 1, 2, . . . K and
covariance, l = diag(
l = (EstimateCellCounts or IDOL).
b. For each of the n2 samples in group 2, obtain ω̃(2)
il
by randomly sampling from a multivariate normal
distribution with mean ω(2) and variance(2)
τkl2 ), k = 1, 2, . . . K and
covariance, l = diag(
l = (EstimateCellCounts or IDOL).
6. Fit model 7 to each of the G CpGs, adjusting for cell
composition using the cell type predictions generated
in Step 4. Based on the model fit, test the hypothesis,
H0 : α1g = 0, for g = 1, 2, . . . , G.
7. Calculate the FDR for each method assuming a
nominal p-value cutoff of 0.05 for declaring CpGs as
statistically significant.
8. Repeat steps 1-7.
Since the beta-values for groups 1 and 2 were simulated
assuming no group effect (i.e., assuming α1g = 0),
the methylation profile for groups 1 and 2 differ only
with respect to the dissimilarity in the cell composition
between groups, Dissimilarity := ||ω(1) − ω(2) ||. Thus,
rejections of the hypothesis H0 : α1g = 0 based on fitting
model 7 to the simulated data signify Type 1 errors. As a
measure to ensure that the FDR was correctly controlled
at 5 % in models that controlled for the true, simulated
cell distributions, we also augmented our simulation study
with models that included adjustment for terms, ω(1) and
ω(2) .
Data application for exploring the implications of cell
composition adjustment in EWAS

To further understand the implications of cell type
prediction methodology for EWAS (particularly, those
using blood-derived DNA methylation data), we made
use of two of the largest, publicly available, blood-derived
DNA methylation data sets [16, 29]. Our analysis of these
data sets was aimed at addressing two different but related
questions: (i) which cell prediction methodology performed better at explaining variation in DNA methylation
within each data set and (ii) how do differences in the

variation being explained relate to the statistical power
of such studies. To address these questions, we began
by applying CMD [13] for estimating the immune cell
composition of the samples in the Liu and Hannum data
sets. CMD was applied using both the EstimateCellCounts
(default settings) and the optimal IDOL library, giving rise
to two sets of cell type predictions for each of the two
data sets. For each data set, linear regression models were
fit to the J CpG loci independently, modeling methylation beta-values as the response against the predicted cell
distribution. Based on the fitted regression models, we
estimated the variation in methylation unaccounted for
by our estimates of cell mixture (i.e., residual variance)
as well as the proportion of variation in methylation
explained by cell mixture estimates: R2jl , j = 1, 2, . . . , J and
l = {EstimateCellCounts, IDOL}). Using these estimates,
the difference in R2 between models adjusted for cell
mixture using the optimal IDOL library versus EstimateCellCounts were computed for each of the J CpGs; i.e.,
Dj = R2j,IDOL − R2j,EstimateCellCounts .
To answer the first of our questions - which cell prediction methodology performs better at explaining variation in DNA methylation? - we computed the proportion
of CpG loci where the IDOL library resulted in more
variation in DNA methylation
 explained compared to
EstimateCellCounts, i.e., 1J Jj=1 I(Dj > 0). To assess
whether the observed proportion was greater than would
be expected at random, we employed a non-parametric
randomized-based test with a p-value cutoff of 0.05 to
determine statistical significance.
We next sought to compare the impact of different
L-DMR libraries on the statistical power of EWAS.
Similar to our simulation study (Section ‘Simulation
study comparing false discovery rates (FDR) across
different cell composition adjustment techniques’), we
assumed a simple study design that was aimed at
identifying differences in the mean methylation levels
between two groups. Using the residual variance estimates
obtained above, we computed the sample size required
for identifying differences in the mean methylation levels
between groups that ranged from 0.01 to 0.05 on the betavalue scale. For our sample size estimates, we assumed a
two-sample t-test, 80 % power, and Bonferroni corrected
type 1 error rate (i.e, α/400, 000) to account for issue of
multiple testing encountered in EWAS. Within both the
Liu and Hannum data sets, we randomly sampled the
residual variance estimates for 1000 CpG loci obtained for
each cell mixture correction methodology and computed
the sample size needed for detecting a difference in
mean methylation based on the previously mentioned
assumptions. For a given difference in mean methylation,
the sample size estimates based on the 1000 randomly
sampled residual variance estimates were summarized by

Koestler et al. BMC Bioinformatics (2016) 17:120

computing the mean, which formed the basis for our
comparisons.
To highlight the economic implications of our findings,
we also estimated the cost-differential for EWAS when
cell mixture correction was carried out using the IDOL
library versus EstimateCellCounts based on our estimates of the required sample sizes for each methodology. Cost-differential estimates were obtained by using
the current per-sample cost of the Illumina HumanMethylation450 array of approximately 300 US dollars
(http://www.illumina.com/).
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